In a groundbreaking advance that reshapes our understanding of HIV persistence and viral evolution, researchers have unveiled compelling evidence that superinfection — the phenomenon where an individual already infected with HIV acquires a second genetically distinct HIV strain — can promote the replication and diversification of defective HIV-1 proviruses in people with non-suppressible viremia. This discovery not only challenges long-held assumptions about defective proviruses as inert relics but also significantly deepens the complexity of HIV persistence under antiretroviral therapy. The latest study, published in Nature Microbiology, offers a nuanced mechanistic insight into why some individuals fail to achieve full viral suppression despite rigorous treatment.
HIV infection is characterized by the integration of viral DNA, termed proviruses, into the host genome. A striking majority of these integrated proviruses are defective, harboring lethal mutations or deletions that theoretically render them incapable of producing infectious virus. Traditionally, these defective proviruses were considered biologically silent passengers within infected cells, contributing little to active viral replication or immune activation. However, the new data reveal that superinfection can provide a catalyzing environment that revitalizes these defective sequences, enabling them to replicate and diversify within the host, especially in individuals experiencing persistent low-level viremia that is unresponsive to suppressive therapy.
The study focused on a cohort of people living with HIV who exhibit non-suppressible viremia — a clinical phenotype where plasma viral levels remain detectable despite adherence to optimized combination antiretroviral therapy (ART). By employing advanced single-cell genomics and viral sequencing techniques, the researchers meticulously charted the landscape of proviral genomes residing within these individuals’ circulating CD4+ T cells. The high-resolution mapping uncovered a striking overlap between superinfecting strains and the enhanced replication activity traced back to defective proviruses, fundamentally linking the phenomenon of superinfection with the puzzling persistence of viremia.
Mechanistically, the findings suggest that superinfection introduces additional viral proteins and genomic elements that can complement defective proviruses. This complementation allows them to bypass intrinsic genetic defects and engage the host’s replication machinery, thereby producing viral particles. Importantly, the study did not identify direct rescue of infectivity but noted increased transcriptional activity and diversification at the proviral level. This stands to suggest that the presence of multiple HIV genomes within the same cell furnishes the molecular toolkit needed for defective genomes to evolve and perhaps regain partial replication competence over time.
Notably, the research highlighted that superinfection is not merely a sporadic event but may be a clinically relevant mechanism exacerbating viral persistence and hindering treatment success. This is particularly significant given that current antiretroviral strategies are designed primarily to suppress viral replication and reduce reservoirs of intact, replication-competent proviruses. The ability of defective proviruses to reactivate and diversify under the influence of superinfection introduces a new layer of difficulty in eradicating HIV and underscores the potential need to reconsider strategies for therapeutic intervention.
Further, the study emphasizes the evolutionary plasticity of HIV within the host environment. Viral diversification driven by superinfecting strains may contribute to the genesis of novel viral quasispecies that can evade immune surveillance and antiretroviral drugs. This diversification was observed through high-throughput sequencing approaches that revealed robust heterogeneity among proviral genomes in individuals with ongoing viremia despite therapy. The sequence variability arose not only from recombination but also from mutation accumulation facilitated by the dynamic intracellular milieu during superinfection.
This research also shines a light on the biological consequences of proviral diversity in immune activation and pathogenesis. Defective proviruses reactivated during superinfection could contribute to chronic immune activation, a hallmark of HIV-associated morbidity, by producing viral RNA transcripts and proteins that engage innate immune sensors. Such persistent immune stimulation may exacerbate inflammation and drive comorbidities, complicating clinical management even when plasma viral load appears relatively stable.
To deepen the implications for HIV cure research, the authors propose that defective proviruses should no longer be dismissed as irrelevant remnants. Instead, their potential to replicate and diversify under certain conditions mandates their consideration in reservoir analyses and in the design of eradication strategies. The study advocates for more refined diagnostics capable of capturing the dynamic behavior of defective proviruses, especially in patients with non-suppressible viremia.
Clinically, these results prompt re-evaluation of monitoring practices. Patients exhibiting persistent viremia might need assessment for superinfection events, as these could portend a worse prognosis or require intensified therapeutic regimens. Such monitoring might entail longitudinal viral sequencing coupled with immune profiling to detect early signs of proviral reactivation or viral diversification.
The study moreover raises intriguing questions about the roles of immune responses and coinfections in modulating superinfection-induced reactivation. How cellular immunity influences the fate of defective proviruses during superinfection remains to be elucidated. Understanding these interactions could uncover novel targets for immunotherapeutic approaches aimed at controlling or eliminating these “silent” but potentially dangerous viral genomes.
From a virological standpoint, the findings underscore the intricacies of HIV latency and reservoir dynamics. They indicate that latency is a highly plastic state, not a static one, with defective sequences capable of switching to active replication under appropriate stimuli, such as superinfection. This paradigm shift calls for a reevaluation of latency models and highlights the necessity of considering proviral heterogeneity in therapeutic designs.
In the broader context of HIV research, this work injects critical nuance into the ongoing quest for functional cure or eradication. By revealing a hidden pathway through which defective proviruses can be reactivated and diversify, the authors encourage the field to develop innovative ways to detect, suppress, or eliminate these proviruses before they contribute to viral rebound or disease progression.
The role of superinfection in HIV evolution within the host also has implications for vaccine development. Vaccines aiming to elicit robust and broad immune responses may need to address the possibility of superinfection driving viral diversity and immune escape. Designing vaccines that can block or mitigate superinfection events could be vital for long-term control of HIV.
Methodologically, the study stands out due to its comprehensive use of integrated viral and host genomic data. The authors utilized cutting-edge single-cell RNA sequencing technologies alongside traditional virological assays, enabling a holistic surveillance of viral behavior within individual host cells. This integrative approach sets a new standard for future investigations into viral reservoirs and reactivation phenomena.
Looking forward, these findings open multiple avenues for future research aimed at unraveling the molecular details governing the interplay between defective proviruses and superinfecting viral strains. Elucidating the precise viral factors or host cofactors that facilitate defective proviral replication could result in novel pharmacological targets, potentially ushering in therapies specifically designed to prevent reactivation and diversification.
In conclusion, the revelation that superinfection can promote the replication and diversification of defective HIV-1 proviruses in people with non-suppressible viremia forces a fundamental rethinking of HIV persistence. It suggests that the latent reservoir is far more dynamic and adaptable than previously appreciated, with significant clinical and therapeutic ramifications. As the global HIV research community strives toward eradication, incorporating these insights will be crucial for designing next-generation strategies that address all facets of proviral biology, not just those of replication-competent viruses.
Subject of Research: The dynamics of HIV-1 defective provirus replication and diversification influenced by superinfection in individuals with non-suppressible viremia.
Article Title: Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia.
Article References:
Hariharan, V., White, J.A., Dragoni, F. et al. Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02135-z
Image Credits: AI Generated
